Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
OrthoSpineNews
MAY 13, 2025
Food and Drug Association (FDA) is requiring at least a greater than 30% improvement in both Oswestry Disability Index (ODI) and Visual Analog Scale (VAS ); ongoing clinical data demonstrates trends greater than 30% improvements in both measures. 12 13.33% 26 46.15% 52 70.0% 12 13.33% 26 46.15% 52 70.0%
Let's personalize your content